Women's health

How physicians can help patients overcome the symptoms of genitourinary syndrome of menopause.

Product monographs are being updated to include the risk of serious hypertension, myocardial infarction (MI), stroke and seizures in postpartum women taking cabergoline.

The painful condition, which causes tissue similar to the lining of the uterus to grow on other parts of the body, afflicts 1 in 10 women worldwide.

New benefits data points to growing use of hormone therapy to manage menopause symptoms.

About two weeks after giving birth, Bridget María Chesterton was curled up on the bathroom floor, saying things that made little sense.

Women aged 35 to 54 drink the most, according to a U.S. national survey. Yet many underestimate how drinking above the recommended guidelines could affect their breast cancer risk.

When a pharmacy team in Shawinigan discussed which cause they wanted to support in 2026, the choice was obvious.

Study examines whether progestogens used in hormonal contraceptives are linked to an increased risk of meningioma, the most common intracranial tumour in adults.

Elinzanetant, also known by the brand name Lynkuet, was first approved in July 2025 to treat the symptoms in women going through menopause.

PMDD has long been considered a severe form of PMS but differs because it causes serious mood and emotional problems and is a chronic, lifelong condition.